Step One Is Identifying the Right Product Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, to reduce major adverse cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Retatrutide delivers unmatched weight loss and broader metabolic effects, but comes with less accessibility and ongoing research considerations
When properly managed, these therapies can be life-changing, restoring bala
The process varies by insurer, but the general steps are consistent: request the denial in writing (the insurer must provide the specific reason), have your prescriber write a letter of medical necessity that addresses the denial reason directly, include supporting clinical data (STEP, SURMOUNT, SELECT trial results), and submit within the appeal deadline (typically 60 to 180 days depending on the plan)